Below you'll find a list of all posts that have been tagged as “Martin Shkreli”
Martin Shkreli, the former hedge-fund manager turned pharmaceutical CEO who was arrested last week, has been described as a sociopath and worse. In reality, he’s a brasher and larger version of what others in finance and corporate suites do all the time. Federal prosecutors are charging him with conning wealthy investors. Lying to investors is illegal, of course, but it’s …
Martin Shkreli, the pharmaceutical CEO arrested on securities fraud charges this week, may have made drug price increases notorious in the U.S. But his strategy of finding an old drug, raising its price, and taking the profit is one that’s increasingly common among a new breed of drugmakers. Disdaining a business model dependent on expensive research and development, companies like …
“I feel very angry, but I don’t want anything from the U.S. military,” said Khalid Ahmad, a 20 year old pharmacist who survived the U.S. bombing of the Médecins Sans Frontières (MSF) / Doctors Without Borders Hospital in Kunduz on the 3rd of October, “God will hold them accountable.” The actions of the U.S. military elicit the same contempt from Khalid …
Another Pharmaceutical CEO is stepping up to challenge Martin Shkreli as world’s most hated man. Last month, Martin Shkreli became a household name. The CEO of Turing Pharmaceuticals is now infamous for raising the price of a newly-acquired drug to $750 a pill. He also explained in an interview that his company was not alone in acquiring drugs currently on …
The decision by biotechnology firm Turing Pharmaceuticals to raise the cost of Pyrimethamine (or Daraprim), a drug used to treat toxoplasmosis, from $13.50 to more than $750 per pill, has aroused shock and outrage. Toxoplasmosis is a parasitic disease to which people with weakened immune systems from of diseases such as AIDS, as well as certain cancer patients, as well …
Martin Shkreli, the controversial pharmaceutical CEO and former hedge fund manager, announced that he would reduce the price of the drug Daraprim to “a point that is more affordable.” Shkreli has been the subject of unrelenting criticism since he implemented a 5000% increase in the price of the drug — from $13.50 per pill to $750 — which is used …
“Martin Shkreli is the Donald Trump of drug development,” my friend Frank tells me. “He’s a hedge fund manager who gives hedge fund managers a bad name.” Frank — a chief scientific officer at a biotech company (and whose name has been changed to protect his and his family’s privacy) — is talking to me Tuesday morning, en route to …
